Compounds > rosiglitazone
Page last updated: 2024-08-25

rosiglitazone and Endotoxemia

rosiglitazone has been researched along with Endotoxemia in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Antunes, BM; Batatinha, HAP; Franchini, E; Lira, FS; Rosa-Neto, JC; Teixeira, AM1
Constantin-Teodosiu, D; Crossland, H; Gardiner, SM; Greenhaff, PL1
Ao, JP; Li, HH; Li, YS; Lv, X; Song, JG; Song, SL; Wang, XR; Zhang, P1
Geng, ZL; Liu, D; Wang, YL; Zeng, BX; Zeng, L; Zhang, SF; Zhang, SH1
Liu, D; Yao, SL; Zeng, BX; Zhang, SH1
Henney, JE1

Other Studies

6 other study(ies) available for rosiglitazone and Endotoxemia

ArticleYear
Physical fitness status modulates the inflammatory proteins in peripheral blood and circulating monocytes: role of PPAR-gamma.
    Scientific reports, 2020, 08-24, Volume: 10, Issue:1

    Topics: Adult; Cells, Cultured; Endotoxemia; Exercise; Humans; Hypoglycemic Agents; Interleukin-10; Interleukin-6; Leukocytes, Mononuclear; Lipopolysaccharides; Male; Oxygen Consumption; Physical Fitness; PPAR gamma; Rosiglitazone; Tumor Necrosis Factor-alpha

2020
Peroxisome proliferator-activated receptor γ agonism attenuates endotoxaemia-induced muscle protein loss and lactate accumulation in rats.
    Clinical science (London, England : 1979), 2017, Jul-01, Volume: 131, Issue:13

    Topics: Animals; Drug Evaluation, Preclinical; Endotoxemia; Gene Expression Regulation; Interleukin-6; Lactic Acid; Male; Muscle Proteins; Muscle, Skeletal; PPAR gamma; Rats, Sprague-Dawley; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha

2017
Decreased hepatic peroxisome proliferator-activated receptor-γ contributes to increased sensitivity to endotoxin in obstructive jaundice.
    World journal of gastroenterology, 2011, Dec-28, Volume: 17, Issue:48

    Topics: Alanine Transaminase; Animals; Bile Ducts; Cholestasis; Endotoxemia; Endotoxins; Hypoglycemic Agents; Interleukin-1; Interleukin-6; Jaundice, Obstructive; Ligation; Liver; Male; Peroxisomes; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Survival Rate; Thiazolidinediones; Tumor Necrosis Factor-alpha

2011
Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, reduces acute lung injury in endotoxemic rats.
    Critical care medicine, 2005, Volume: 33, Issue:10

    Topics: Anilides; Animals; Endotoxemia; Lipopolysaccharides; Lung; Male; Nitric Oxide; Nitric Oxide Synthase Type II; PPAR gamma; Rats; Rats, Wistar; Respiratory Distress Syndrome; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Tyrosine

2005
Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2005, Volume: 54, Issue:11

    Topics: Anilides; Animals; Anti-Inflammatory Agents; Blotting, Western; Chemokine CXCL1; Chemokines, CXC; Endotoxemia; Immunohistochemistry; Intercellular Adhesion Molecule-1; Intercellular Signaling Peptides and Proteins; Lipid Peroxidation; Lung; Male; Malondialdehyde; Neutrophil Infiltration; NF-kappa B; Peroxidase; Pneumonia; PPAR gamma; Pulmonary Edema; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha

2005
From the Food and Drug Administration.
    JAMA, 1999, Sep-08, Volume: 282, Issue:10

    Topics: Diabetes Mellitus, Type 2; Endotoxemia; Gentamicins; Humans; Hypoglycemic Agents; Joint Prosthesis; Pioglitazone; Rosiglitazone; Temporomandibular Joint; Temporomandibular Joint Disorders; Thiazoles; Thiazolidinediones; United States; United States Food and Drug Administration

1999